AGP Picks
View all

Technology Journal Nepal
Provided by AGP

Technology Journal Nepal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal Nepal.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 14, 2026

Enko Chem ENKOMPASS™ Named “AI-based AgTech Platform of the Year” By AgTech Breakthrough
Sep. 14, 2026

Enko Chem ENKOMPASS™ Named “AI-based AgTech Platform of the Year” By AgTech Breakthrough

Indeterminate GlobeNewswire
Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
Sep. 14, 2026

Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models

Indeterminate GlobeNewswire
HiBob CPO Named 2026 HR Leader of Distinction by HR Executive
Sep. 14, 2026

HiBob CPO Named 2026 HR Leader of Distinction by HR Executive

Indeterminate GlobeNewswire
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
Sep. 14, 2026

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

Indeterminate GlobeNewswire
Acquia Research Finds CMOs and CIOs Don't Agree on Who Leads Their Shared AI Decisions
Sep. 14, 2026

Acquia Research Finds CMOs and CIOs Don't Agree on Who Leads Their Shared AI Decisions

Indeterminate GlobeNewswire
Alveus Therapeutics Initiates Phase 2 PRESERVE Trial to Evaluate ALV-100 for Chronic Weight Management
Sep. 14, 2026

Alveus Therapeutics Initiates Phase 2 PRESERVE Trial to Evaluate ALV-100 for Chronic Weight Management

Indeterminate GlobeNewswire
Revelyx Bio Reports Positive Topline Phase 2 Results for YY003, a Recombinant, Ready-to-Use Liquid Botulinum Toxin Type A, in Moderate-to-Severe Glabellar Lines
Sep. 14, 2026

Revelyx Bio Reports Positive Topline Phase 2 Results for YY003, a Recombinant, Ready-to-Use Liquid Botulinum Toxin Type A, in Moderate-to-Severe Glabellar Lines

Indeterminate GlobeNewswire
Satellogic Supports HEO RPO Mission Operations
Sep. 14, 2026

Satellogic Supports HEO RPO Mission Operations

Indeterminate GlobeNewswire
Satellogic Expands Slingshot III Work with IDT and U.S. Office of Naval Research
Sep. 14, 2026

Satellogic Expands Slingshot III Work with IDT and U.S. Office of Naval Research

Indeterminate GlobeNewswire
VelocityEHS Brings Data-Driven, AI-Powered Approach to the Future of Workplace Safety at the 2026 NSC Safety Congress & Expo
Sep. 14, 2026

VelocityEHS Brings Data-Driven, AI-Powered Approach to the Future of Workplace Safety at the 2026 NSC Safety Congress & Expo

Indeterminate GlobeNewswire
Rocket Doctor AI Provides Operational Update for U.S. Operations for First Two Months of Q3 2026 Ahead of Global Company Town Hall
Sep. 14, 2026

Rocket Doctor AI Provides Operational Update for U.S. Operations for First Two Months of Q3 2026 Ahead of Global Company Town Hall

Indeterminate GlobeNewswire
Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
Sep. 14, 2026

Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis

Indeterminate GlobeNewswire
Leios Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for 10XB-101 for Moderate-to-Severe Submental Fat Fullness
Sep. 14, 2026

Leios Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for 10XB-101 for Moderate-to-Severe Submental Fat Fullness

Indeterminate GlobeNewswire
Braiin Ltd. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep. 14, 2026

Braiin Ltd. to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases
Sep. 14, 2026

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases

Indeterminate GlobeNewswire
Satellogic to Launch Two ISL-Equipped Satellites and Sovereign Mark V in October
Sep. 14, 2026

Satellogic to Launch Two ISL-Equipped Satellites and Sovereign Mark V in October

Indeterminate GlobeNewswire
FactSet to Host Investor Day on November 10, 2026
Sep. 14, 2026

FactSet to Host Investor Day on November 10, 2026

Indeterminate GlobeNewswire
Sixthfin UK Financial Close Automation Research Finds Account Reliability the Top Priority for 67% of Enterprise Finance Teams and Only 42% Satisfied With Close Management
Sep. 14, 2026

Sixthfin UK Financial Close Automation Research Finds Account Reliability the Top Priority for 67% of Enterprise Finance Teams and Only 42% Satisfied With Close Management

Indeterminate GlobeNewswire
3 E Network Deploys CFD Simulation and Digital Twin Technologies for Mikkeli AI Data Center
Sep. 14, 2026

3 E Network Deploys CFD Simulation and Digital Twin Technologies for Mikkeli AI Data Center

Indeterminate GlobeNewswire
Dr. Sanjeev Goel, M.D., Founder of Peak Human, Introduces Two Free Digital Tools for Personalized Nutrition Tracking and Physician-Guided Care
Sep. 14, 2026

Dr. Sanjeev Goel, M.D., Founder of Peak Human, Introduces Two Free Digital Tools for Personalized Nutrition Tracking and Physician-Guided Care

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Journal Nepal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.